Eric Santoni‐Rugiu

Author

Eric Santoni‐Rugiu

Also Known As

E Santoni-Rugiu, E. Santoni Rugiu, E. Santoni-Rugiu, ERIC SANTONI‐RUGIU, Eric Santoni Rugiu, Eric Santoni-Rigui, Eric Santoni-Rugiu, Eric Santoni‐Rugiu, Santoni Rugiu, Eric

191

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Rigshospitalet Copenhagen University Hospital University of Copenhagen National Cancer Institute Danish Cancer Society

About

Eric Santoni‐Rugiu is an author at Rigshospitalet specializing in medicine, cell biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	34	1.8K
2	Cell Biology	19	23	1.5K
3	Health Sciences	8	8	326
4	Natural Sciences	4	4	399
5	Biochemistry	3	3	320

Eric Santoni‐Rugiu

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex Claudia Lukas, Claus Storgaard Sørensen, Edgar R. Kramer, Nature Protein FunctionSignal TransductionCell RegulationBiochemistryCell Division	1999	283
Involvement of Myc Activity in a G<sub>1</sub>/S-Promoting Mechanism Parallel to the pRb/E2F Pathway Eric Santoni‐Rugiu, Jacob Falck, Niels Mailand, Molecular and Cellular Biology	2000	163
Transit-Amplifying Ductular (Oval) Cells and Their Hepatocytic Progeny Are Characterized by a Novel and Distinctive Expression of Delta-Like Protein/Preadipocyte Factor 1/Fetal Antigen 1 Charlotte Harken Jensen, Eva Irene Jauho, Eric Santoni‐Rugiu, American Journal Of Pathology HistocompatibilityCell LineageDevelopmental BiologyHepatologyLiver Physiology	2004	142
The Histone Methyltransferase and Putative Oncoprotein MMSET Is Overexpressed in a Large Variety of Human Tumors Heidi Rye Hudlebusch, Eric Santoni‐Rugiu, Ronald Simon, Clinical Cancer Research	2011	139
Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution Subramanian Venkatesan, Mihaela Angelova, Clare Puttick, Cancer Discovery	2021	137
PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab Jeanette Dupont Jensen, Ann Knoop, Morten Grauslund, Annals of Oncology Pher2 ExpressionBreast OncologyMedicineAdjuvant ChemotherapyPik3ca Mutations	2011	135
Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Eric Santoni‐Rugiu, Michael Rugaard Jensen, S S Thorgeirsson PubMed ApoptosisPathologyCell DeathC-myc/tgfalpha HccsCell Proliferation	1998	123
Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Eric Santoni‐Rugiu, Karl‐Heinz Preisegger, András Kiss, Proceedings of the National Academy of Sciences PathologyLiver CarcinogenesisTransgenic Mouse ModelTumor BiologyCirrhosis	1996	121
Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Eric Santoni‐Rugiu, Péter Nagy, Michael Rugaard Jensen, PubMed	1996	119
Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell–mediated liver regeneration Peter Jelnes, Eric Santoni‐Rugiu, Morten Rasmussen, Hepatology	2007	116

Page 1